Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Current Assets (2019 - 2025)

Silo Pharma's Current Assets history spans 7 years, with the latest figure at $6.2 million for Q3 2025.

  • For Q3 2025, Current Assets fell 25.39% year-over-year to $6.2 million; the TTM value through Sep 2025 reached $6.2 million, down 25.39%, while the annual FY2024 figure was $7.1 million, 7.42% down from the prior year.
  • Current Assets for Q3 2025 was $6.2 million at Silo Pharma, down from $6.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $12.9 million in Q3 2022 and bottomed at $5.0 million in Q2 2021.
  • The 5-year median for Current Assets is $8.3 million (2024), against an average of $8.5 million.
  • The largest annual shift saw Current Assets skyrocketed 1257.5% in 2021 before it tumbled 37.21% in 2024.
  • A 5-year view of Current Assets shows it stood at $10.4 million in 2021, then increased by 11.24% to $11.6 million in 2022, then tumbled by 33.62% to $7.7 million in 2023, then fell by 7.42% to $7.1 million in 2024, then decreased by 13.32% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Current Assets are $6.2 million (Q3 2025), $6.4 million (Q2 2025), and $5.6 million (Q1 2025).